Publication:
Identifying clinical characteristics of hypoparathyroidism in Turkey: HIPOPARATURK-NET study

dc.contributor.authorDeğertekin, Ceyla Konca
dc.contributor.authorYavuz, Dilek Gogas
dc.contributor.authorPekkolay, Zafer
dc.contributor.authorSaygılı, Emre
dc.contributor.authorUğur, Kader
dc.contributor.authorKoca, Arzu Or
dc.contributor.authorÜnübol, Mustafa
dc.contributor.authorTopaloğlu, Ömercan
dc.contributor.authorAydoğan, Berna İmge
dc.contributor.authorKutbay, Nilüfer Özdemir
dc.contributor.authorHekimsoy, Zeliha
dc.contributor.authorYılmaz, Nusret
dc.contributor.authorBalcı, Mustafa Kemal
dc.contributor.authorTanrıkulu, Seher
dc.contributor.authorÜnsal, Yasemin Aydoğan
dc.contributor.authorErsoy, Canan
dc.contributor.authorOmma, Tülay
dc.contributor.authorKeskin, Müge
dc.contributor.authorYalçın, Mehmet Muhittin
dc.contributor.authorYetkin, İlhan
dc.contributor.authorSoylu, Hikmet
dc.contributor.authorKaraköse, Melia
dc.contributor.authorYılmaz, Merve
dc.contributor.authorKarakılıç, Ersen
dc.contributor.authorPişkinpaşa, Hamide
dc.contributor.authorBatman, Adnan
dc.contributor.authorAkbaba, Gülhan
dc.contributor.authorElbuken, Gülşah
dc.contributor.authorBahadir, Cigdem Tura
dc.contributor.authorKılınç, Faruk
dc.contributor.authorBilginer, Muhammet Cüneyt
dc.contributor.authorİyidir, Özlem Turhan
dc.contributor.authorCantürk, Zeynep
dc.contributor.authorYılmaz, Banu Aktaş
dc.contributor.authorSayıner, Zeynel Abidin
dc.contributor.authorEroğlu, Mustafa
dc.contributor.buuauthorERSOY, CANAN
dc.contributor.departmentBursa Uludağ Üniversitesi/Tıp Fakültesi/Endokrinoloji ve Metabolizma Hastalıkları Bilim Dalı
dc.contributor.researcheridAAH-8861-2021
dc.date.accessioned2024-06-11T06:05:33Z
dc.date.available2024-06-11T06:05:33Z
dc.date.issued2022-02
dc.description.abstractHypoparathyroidism is an orphan disease with ill-defined epidemiology that is subject to geographic variability. We conducted this study to assess the demographics, etiologic distribution, treatment patterns and complication frequency of patients with chronic hypoparathyroidism in Turkey. This is a retrospective, cross-sectional database study, with collaboration of 30 endocrinology centers located in 20 cities across seven geographical regions of Turkey. A total of 830 adults (mean age 49.6 +/- 13.5 years; female 81.2%) with hypoparathyroidism (mean duration 9.7 +/- 9.0 years) were included in the final analysis. Hypoparathyroidism was predominantly surgery-induced (n = 686, 82.6%). The insulting surgeries was carried out mostly due to benign causes in postsurgical group (SG) (n = 504, 73.5%) while patients in nonsurgical group (NSG) was most frequently classified as idiopathic (n = 103, 71.5%). The treatment was highly dependent on calcium salts (n = 771, 92.9%), calcitriol (n = 786, 94.7%) and to a lower extent cholecalciferol use (n = 635, 76.5%) while the rate of parathyroid hormone (n = 2, 0.2%) use was low. Serum calcium levels were most frequently kept in the normal range (sCa 8.5-10.5 mg/dL, n = 383, 46.1%) which might be higher than desired for this patient group. NSG had a lower mean plasma PTH concentration (6.42 +/- 5.53 vs. 9.09 +/- 7.08 ng/l, p < 0.0001), higher daily intake of elementary calcium (2038 +/- 1214 vs. 1846 +/- 1355 mg/day, p = 0.0193) and calcitriol (0.78 +/- 0.39 vs. 0.69 +/- 0.38 mcg/day, p = 0.0057), a higher rate of chronic renal disease (9.7% vs. 3.6%, p = 0.0017), epilepsy (6.3% vs. 1.6%, p = 0.0009), intracranial calcifications (11.8% vs. 7.3%, p < 0.0001) and cataracts (22.2% vs. 13.7%, p = 0.0096) compared to SG. In conclusion, postsurgical hypoparathyroidism is the dominant etiology of hypoparathyroidism in Turkey while the nonsurgical patients have a higher disease burden with greater need for medications and increased risk of complications than the postsurgical patients.
dc.identifier.doi10.1007/s00223-021-00908-2
dc.identifier.endpage214
dc.identifier.issn0171-967X
dc.identifier.issn1432-0827
dc.identifier.issue2
dc.identifier.pubmed34495356
dc.identifier.startpage204
dc.identifier.urihttps://doi.org/10.1007/s00223-021-00908-2
dc.identifier.urihttps://link.springer.com/article/10.1007/s00223-021-00908-2
dc.identifier.urihttps://hdl.handle.net/11452/41955
dc.identifier.volume110
dc.identifier.wos000695738900001
dc.indexed.pubmedPubMed
dc.indexed.wosWOS.SCI
dc.language.isoen
dc.publisherSpringer
dc.relation.journalCalcified Tissue International
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectPostsurgical hypoparathyroidism
dc.subjectFollow-up
dc.subjectEpidemiology
dc.subjectComplications
dc.subjectHypoparathyroidism
dc.subjectHypocalcemia
dc.subjectEpidemiology
dc.subjectTurkey
dc.subjectParathyroid hormone
dc.subjectScience & technology
dc.subjectLife sciences & biomedicine
dc.subjectEndocrinology & metabolism
dc.titleIdentifying clinical characteristics of hypoparathyroidism in Turkey: HIPOPARATURK-NET study
dc.typeArticle
dspace.entity.typePublication
relation.isAuthorOfPublication1a528bc6-7850-41a4-a7cc-1b7f1aded115
relation.isAuthorOfPublication.latestForDiscovery1a528bc6-7850-41a4-a7cc-1b7f1aded115

Files